Osteoclast Activity and Subtypes as a Function of Physiology and Pathology-Implications for Future Treatments of Osteoporosis

被引:185
作者
Henriksen, K. [1 ]
Bollerslev, J. [2 ,3 ]
Everts, V. [4 ,5 ]
Karsdal, M. A. [1 ]
机构
[1] Nord Biosci AS, Hovedgade 207, DK-2730 Herlev, Denmark
[2] Natl Hosp Norway, Oslo Univ Hosp, Dept Med, Sect Endocrinol, N-0450 Oslo, Norway
[3] Univ Oslo, N-0450 Oslo, Norway
[4] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, NL-1066 EA Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Res Inst Move, NL-1066 EA Amsterdam, Netherlands
关键词
RESISTANT ACID-PHOSPHATASE; AUTOSOMAL-DOMINANT OSTEOPETROSIS; BONE-MINERAL DENSITY; TUMOR-NECROSIS-FACTOR; MATRIX-METALLOPROTEINASE INHIBITORS; ESTROGEN-RECEPTOR-ALPHA; CATHEPSIN-K INHIBITOR; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; HORMONE REPLACEMENT THERAPY; CARTILAGE TURNOVER MARKERS;
D O I
10.1210/er.2010-0006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoclasts have traditionally been associated exclusively with catabolic functions that are a prerequisite for bone resorption. However, emerging data suggest that osteoclasts also carry out functions that are important for optimal bone formation and bone quality. Moreover, recent findings indicate that osteoclasts have different subtypes depending on their location, genotype, and possibly in response to drug intervention. The aim of the current review is to describe the subtypes of osteoclasts in four different settings: 1) physiological, in relation to turnover of different bone types; 2) pathological, as exemplified by monogenomic disorders; 3) pathological, as identified by different disorders; and 4) in drug-induced situations. The profiles of these subtypes strongly suggest that these osteoclasts belong to a heterogeneous cell population, namely, a diverse macrophage-associated cell type with bone catabolic and anabolic functions that are dependent on both local and systemic parameters. Further insight into these osteoclast subtypes may be important for understanding cell-cell communication in the bone microenvironment, treatment effects, and ultimately bone quality. (Endocrine Reviews 32: 31-63, 2011)
引用
收藏
页码:31 / 63
页数:33
相关论文
共 381 条
  • [31] Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification
    Bossard, MJ
    Tomaszek, TA
    Thompson, SK
    Amegadzie, BY
    Hanning, CR
    Jones, C
    Kurdyla, JT
    McNulty, DE
    Drake, FH
    Gowen, M
    Levy, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) : 12517 - 12524
  • [32] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [33] Osteoblasts play key roles in the mechanisms of action of strontium ranelate
    Brennan, T. C.
    Rybchyn, M. S.
    Green, W.
    Atwa, S.
    Conigrave, A. D.
    Mason, R. S.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (07) : 1291 - 1300
  • [34] Bisphosphonate therapy in rheumatoid arthritis
    Breuil, Veronique
    Euller-Ziegler, Liana
    [J]. JOINT BONE SPINE, 2006, 73 (04) : 349 - 354
  • [35] CHONDROCLASTS AND OSTEOCLASTS AT SUBCHONDRAL SITES OF EROSION IN THE RHEUMATOID JOINT
    BROMLEY, M
    WOOLLEY, DE
    [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (09): : 968 - 975
  • [36] Brown E. M., 2007, V45, P139
  • [37] Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
    Bruyere, O.
    Collette, J.
    Rizzoli, R.
    Decock, C.
    Ortolani, S.
    Cormier, C.
    Detilleux, J.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (06) : 1031 - 1036
  • [38] Low bone turnover and microdamage? How and where to assess it?
    Burr, David B.
    Allen, Matthew R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (07) : 1150 - 1151
  • [39] Targeted and nontargeted remodeling
    Burr, DB
    [J]. BONE, 2002, 30 (01) : 2 - 4
  • [40] Glucocorticoid-induced osteoporosis: pathophysiology and therapy
    Canalis, E.
    Mazziotti, G.
    Giustina, A.
    Bilezikian, J. P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (10) : 1319 - 1328